Clinical and experimental medicineHumansLatent TuberculosisRheumatic DiseasesTumor Necrosis Factor-alphaAntirheumatic Agents
Non-TNF-targeted drugs in rheumatic diseasescombined with latent tuberculosis infection.
Zhicong Xiang, Liuyu, Hequn Zou
Published: 202610.1007/s10238-025-01959-7
Abstract
Rheumatic diseases(RD), a collection of autoimmune disorders affecting connective tissues, have a global prevalence of approximately 3%-5%. Characterized by immune-mediated attacks on the body's own tissues, these conditions lead to inflammation and…
Preview only. Read the full abstract at the source